This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on September 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Clinical Division Genetic Testing and Next Generation Sequencing Services for Active Clinical Protocols- bone marrow failure syndromes, aplastic anemia, myeloid neoplasms, clonal hematopoiesis, and related hematologic disorders
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Heart, Lung, and Blood Institute (NHLBI) intends to award a noncompetitive sole source purchase order to The University of Chicago Medical Center for comprehensive germline genetic testing and next generation sequencing (NGS) services. This contract supports active clinical protocols focused on bone marrow failure syndromes, aplastic anemia, myeloid neoplasms, clonal hematopoiesis, and related hematologic disorders. The scope of work requires a validated NGS assay capable of analyzing approximately 111 genes, including complete sequence analysis of coding regions and specific 5' untranslated regions for ANKRD26, DKC1, TERC, and TERT. The contractor is responsible for providing specimen collection kits, processing samples using Illumina or equivalent technology, and delivering clinical reports of pathogenic variants via a secure, password-protected web portal. The period of performance consists of a one-year base period with four one-year option years, with all work performed at the University of Chicago Genetics Services Laboratory. The acquisition is governed by FAR Subpart 12.102(a) and includes standard commercial item clauses, with payments processed via Electronic Funds Transfer. To establish bona fide capabilities, the contractor must maintain all necessary clinical laboratory certifications and adhere to strict federal regulations regarding patient data confidentiality and security. The solicitation, identified as 75N98026Q01002 under NAICS code 622110, requires responses to be submitted by September 8, 2026, including detailed pricing, business size certification, and UEI/TIN identifiers.
General Info
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
See attached Notice of Intent and Statement of Work for details.
More opportunities from Department Of Health And Human Services → National Institutes Of Health Nhlbi
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
